TESTOSTERONE REPLACEMENT THERAPY CLINIC BUSINESS PLAN

I. Executive Summary

Company Description

Renew Men’s Clinic, named for its focus on restoring physiological vitality, is a specialized medical practice in the U.S. men’s hormonal health sector launching in 2026. We deliver a medically supervised, data-driven hormone replacement therapy (HRT) program for men aged 35+, combining advanced diagnostics, evidence-based protocols, and personalized treatment plans. Core services include comprehensive hormonal panels, individualized dosing, injectable and topical therapies, metabolic and fitness counseling, and ongoing lab-driven monitoring. We operate on a fee-for-service model in a premier clinical environment designed for repeat, longitudinal care.

The clinic’s daily activities include patient intake and diagnostic testing, clinician consultations, medication management, telehealth follow-ups, and outcome tracking via an EMR-linked dashboard. What sets us apart is our integrated care pathway: protocolized diagnostics, measurable outcome targets, and a concierge-level patient experience that prioritizes safety and adherence. Target customers are men 35+ in high-growth U.S. metro markets seeking measurable improvements in energy, cognition, and performance. Short-term goals: open in 2026, hire a 6-person medical team, and reach break-even in year one. Long-term goals: scale to 22 practitioners by 2030 and replicate the clinic model across three additional markets.

Problem

Millions of American men have clinically low testosterone that reduces energy, mental clarity, and physical performance; many cases go undiagnosed or are poorly managed because primary care often lacks hormonal-specialty expertise. This gap causes persistent symptoms, reduced work output, and strained relationships.

The market is underserved by care that combines endocrinology-level assessment, individualized dosing, continuous monitoring, and confidential delivery. Existing pathways rely on generalist evaluation, one-size-fits-all treatments, or tele-only models that compromise safety, long-term outcomes, and patient privacy.

There is a clear need for a medically supervised, data-driven program serving men 35+, delivered in a professional clinic setting. The proposed clinic will launch in 2026 on a fee-for-service basis and scale from a 6-person medical team to 22 practitioners by 2030 to close this care gap.

Solution

We provide a medically supervised, data-driven hormone replacement therapy program that restores and maintains healthy hormone levels for men suffering from low testosterone, chronic fatigue, brain fog, and reduced stamina. The clinic fills a market gap for a high-touch, discreet, professional men's-health environment that attracts high-performing patients who avoid generic, one-size-fits-all care.

The program uses extensive blood-panel diagnostics through national lab partners to create personalized treatment plans, led by a Senior Medical Director and delivered by trained Nurse Practitioners. We perform regular follow-ups, objective lab monitoring, and therapy adjustments, and provide patient education so men regain vitality and sustain professional and personal performance.

Mission Statement

Our mission is to empower men to reclaim vitality and peak performance through personalized, data-driven hormonal health solutions. We deliver a premier medical experience that pairs clinical excellence with a high-touch concierge approach, prioritizing safety, transparency, and individualized care. We aim to eliminate symptoms of hormonal decline, help patients lead more energetic, focused lives, and set the standard for specialized men's health services in the United States.

Key Success Factors

Core strengths that drive revenue, margins, and patient retention.

• Specialized medical team: scale to 22 practitioners to support projected $9.3M Year 5 revenue.
• Data-driven clinical model: measurable outcomes and safety that build long-term loyalty and referrals.
• Fast unit economics: breakeven in 1 month and payback in 9 months, enabling rapid reinvestment.
• Strategic clinical partnerships: integrated diagnostics and specialty pharmacy relationships for personalized care.
• Premium patient experience: executive-level service that supports premium pricing in a growing market.

Financial Summary

The clinic projects rapid, profitable growth with strong cash returns and quick payback.

Financial requirements: minimum cash cushion of $781,000 (Feb-26), initial capex $352,000 total, breakeven Jan-26, and a 9-month payback; anticipated return: IRR 20.48% and ROE 18.47%.

Overall financial outlook: high-margin, fast-payback specialty clinic with scalable unit economics.

Funding Requirements

The clinic requires $1,188,000 in total funding to start, targets $1,351,000 revenue and $809,000 EBITDA in Year 1, and offers a 9‑month payback with a projected IRR of 20.48% and ROE of 18.47%.